Skip to Content

AXS Alternative Value Investor COGLX

Medalist Rating as of | See AXS Investment Hub
  • NAV / 1-Day Return 12.87  /  +0.23 %
  • Total Assets 12.8 Mil
  • Adj. Expense Ratio
    1.100%
  • Expense Ratio 2.680%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.12%
  • Turnover 33%

USD | NAV as of May 17, 2024 | 1-Day Return as of May 17, 2024, 10:12 PM GMT+0

Morningstar’s Analysis COGLX

Will COGLX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of a middling Process Pillar rating and a Below Average People Pillar rating limit AXS Alternative Value Investor to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings COGLX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 16.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Akamai Technologies Inc

1.80 239,304
Technology

Costco Wholesale Corp

1.74 231,688
Consumer Defensive

Vertex Pharmaceuticals Inc

1.73 230,707
Healthcare

Cardinal Health Inc

1.69 225,187
Healthcare

International Business Machines Corp

1.67 222,101
Technology

Molina Healthcare Inc

1.66 221,844
Healthcare

Republic Services Inc

1.65 219,990
Industrials

Amgen Inc

1.64 218,031
Healthcare

Regeneron Pharmaceuticals Inc

1.63 217,816
Healthcare

FactSet Research Systems Inc

1.61 215,150
Financial Services